N. Normanno

Molecular Biology · 2006–2022

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom N. Normanno trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Lewis C. Cantley (in Molecular Biology)

Papers from N. Normanno's perspective

Ordered by how strongly the researchers N. Normanno trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Mutations of the BRAF gene in human cancer (Nature)
  2. Ras, PI(3)K and mTOR signalling controls tumour cell growth (Nature)
  3. Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab (Science Translational Medicine)
  4. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
  5. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism (Nature reviews genetics)
  6. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
  7. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. (Journal of Clinical Oncology)
  8. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
  9. Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
  10. Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer (Nature)

Their papers